Skip to main content
    I

    Ionis Pharmaceuticals Inc (IONS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $28.01
    -1.05 (-3.61%)

    Market Cap: $4.84B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Ionis Pharmaceuticals Inc (IONS) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Ionis Pharmaceuticals are Iovance Biotherapeutics (IOVA), Ligand Pharmaceuticals (LGND) and Ideaya Biosciences (IDYA). By market cap, Ionis Pharmaceuticals ranks 6th of the 13 companies on this page; Kodiak Sciences (KOD) is the largest at $7.27B.

    Peer Comparison

    IONS's ROIC of -29.3% is above the peer median of -52.2%, and its revenue growth of 54.9% is above the median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Ionis Pharmaceuticals (IONS)$4.84BN/A4.8x-56.9%-29.3%54.9%0.00%
    Iovance Biotherapeutics Inc (IOVA)$3.59BN/A9.1x-58.2%N/A80.1%0.00%
    Ligand Pharmaceuticals Incorporated (LGND)$6.18B66.5x23.7x20.3%0.1%-31.8%0.00%
    Ideaya Biosciences Inc (IDYA)$3.08BN/A85.5x0.0%N/A-95.1%0.00%
    Tarsus Pharmaceuticals Inc (TARS)$3.96BN/A5.4x-102.9%-393.6%63.9%0.00%
    Dianthus Therapeutics Inc. (DNTH)$5.17BN/AN/A0.0%N/A205.6%0.00%
    Crispr Therapeutics AG (CRSP)$4.10BN/A155.2x0.0%-20.3%1325.0%0.00%
    Legend Biotech Corp (LEGN)$3.39B266.5x2.3x-0.0%N/A32.0%0.00%
    Immunovant Inc (IMVT)$7.07BN/AN/A0.0%N/A0.0%0.00%
    Cogent Biosciences Inc (COGT)$4.97BN/AN/A0.0%-43.4%-100.0%0.00%
    Kodiak Sciences Inc (KOD)$7.27BN/AN/A0.0%-1481.8%0.0%0.00%
    Viking Therapeutics Inc (VKTX)$3.73BN/AN/A0.0%-61.0%0.0%0.00%
    Xenon Pharmaceuticals Inc (XENE)$3.98BN/AN/A0.0%N/A-100.0%0.00%
    Peer median$4.04B166.5x16.4x0.0%-52.2%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Ionis Pharmaceuticals, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Iovance Biotherapeutics Inc (IOVA)
    Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness...
    IOVA competitors
    Ligand Pharmaceuticals Incorporated (LGND)
    Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies discover...
    LGND competitors
    Ideaya Biosciences Inc (IDYA)
    IDEAYA Biosciences, Inc., a synthetic precision medicine oncology company focused on lethality...
    IDYA competitors
    Tarsus Pharmaceuticals Inc (TARS)
    Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new therapeutic candidates...
    TARS competitors
    Dianthus Therapeutics Inc. (DNTH)
    Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company that designs, develops...
    DNTH competitors
    Crispr Therapeutics AG (CRSP)
    CRISPR Therapeutics AG, a gene editing company, focuses on the development of gene-based transformative drugs for serious human diseases.
    CRSP competitors
    Legend Biotech Corp (LEGN)
    Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology...
    LEGN competitors
    Immunovant Inc (IMVT)
    Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases.
    IMVT competitors
    Cogent Biosciences Inc (COGT)
    Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies to treat genetically defined diseases.
    COGT competitors
    Kodiak Sciences Inc (KOD)
    Kodiak Sciences Inc., a clinical-stage biopharmaceutical company, is dedicated to researching, developing...
    KOD competitors
    Viking Therapeutics Inc (VKTX)
    Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing new therapies for metabolic and endocrine disorders.
    VKTX competitors
    Xenon Pharmaceuticals Inc (XENE)
    Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat patients with neurological disorders...
    XENE competitors

    Frequently Asked Questions About IONS

    Who are Ionis Pharmaceuticals' main competitors?

    The companies most similar to Ionis Pharmaceuticals include Iovance Biotherapeutics (IOVA), Ligand Pharmaceuticals (LGND), Ideaya Biosciences (IDYA), Tarsus Pharmaceuticals (TARS) and Dianthus Therapeutics (DNTH), listed from the closest match.

    Who is Ionis Pharmaceuticals' biggest competitor?

    Kodiak Sciences (KOD) is the largest of the similar companies at $7.27B; Iovance Biotherapeutics (IOVA) is the closest match by business profile, size, sector and industry.

    How does IONS stock compare with its competitors?

    IONS' P/S is 4.8x against a peer median of 16.4x; its net margin is -56.9% against a peer median of 0.0%.

    Which of Ionis Pharmaceuticals' competitors pays a higher dividend?

    Ionis Pharmaceuticals pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Ionis Pharmaceuticals bigger than its competitors?

    No. Ionis Pharmaceuticals is 6th by market cap among the 13 companies on this page; the largest is Kodiak Sciences (KOD) at $7.27B.